-
Product Insights
Likelihood of Approval Analysis for Metastatic Hepatocellular Carcinoma (HCC)
Overview How likely is it that the drugs in Metastatic Hepatocellular Carcinoma (HCC) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Hepatocellular Carcinoma (HCC) Overview Metastatic hepatocellular carcinoma (HCC) refers...
-
Product Insights
Likelihood of Approval Analysis for Metastatic Ovarian Cancer
Overview How likely is it that the drugs in Metastatic Ovarian Cancer will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Metastatic Ovarian Cancer Overview Metastatic ovarian cancer results from the spread...
-
Product Insights
Likelihood of Approval Analysis for Ulcers
Overview How likely is it that the drugs in Ulcers will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ulcers Overview Ulcers refer to open sores that develop on the mucous membranes...
-
Product Insights
Likelihood of Approval Analysis for Thrombocytopenia
Overview How likely is it that the drugs in Thrombocytopenia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thrombocytopenia Overview Thrombocytopenia refers to a lower than normal platelet count in the...
-
Product Insights
Likelihood of Approval Analysis for Refractory Chronic Lymphocytic Leukemia (CLL)
Overview How likely is it that the drugs in Refractory Chronic Lymphocytic Leukemia (CLL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Refractory Chronic Lymphocytic Leukemia (CLL) Overview Refractory chronic lymphocytic...
-
Product Insights
Likelihood of Approval Analysis for Acute Coronary Syndrome
Overview How likely is it that the drugs in Acute Coronary Syndrome will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Acute Coronary Syndrome Overview Acute coronary syndrome (ACS) encompasses ST-elevation myocardial...
-
Product Insights
Likelihood of Approval Analysis for Rheumatoid Arthritis
Overview How likely is it that the drugs in Rheumatoid Arthritis will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rheumatoid Arthritis Overview Rheumatoid arthritis (RA) is a chronic autoimmune disorder characterized...
-
Product Insights
Likelihood of Approval Analysis for Transplant Rejection
Overview How likely is it that the drugs in Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Transplant Rejection Overview Transplant rejection is the immune system's response to a...
-
Product Insights
Likelihood of Approval Analysis for Diphtheria
Overview How likely is it that the drugs in Diphtheria will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Diphtheria Overview Diphtheria is a bacterial infection caused by Corynebacterium diphtheriae, primarily affecting...
-
Product Insights
Likelihood of Approval Analysis for Anaplastic Large Cell Lymphoma (ALCL)
Overview How likely is it that the drugs in Anaplastic Large Cell Lymphoma (ALCL) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anaplastic Large Cell Lymphoma (ALCL) Overview Anaplastic Large Cell...